Help Ensure Safe Transitions of Care for Pulmonary Hypertension Patients
March 2017
It's getting harder to keep up with medications for pulmonary hypertension...especially with more patients on combination therapy.
Help ensure safe transitions of care for these patients.
Continue most meds on admission. Avoid interruptions in prostacyclin therapy...especially IV epoprostenol (Flolan, Veletri, etc) and treprostinil (Remodulin) continuous infusions. Abruptly stopping these can lead to life-threatening rebound pulmonary hypertension.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote